aTyr Pharma Publishes Preclinical Anti-Fibrosis Data on ATYR0101
The company reported preclinical anti-fibrotic effects for ATYR0101 and said the program is in IND-enabling studies, with clinic entry expected in 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.